X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ADAG

Closed

Adagene Inc

1.85
-0.10 (-5.13%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.95
Day's Range: 1.74 - 2.1
Send
When Written:
 
1.45
Adagene Inc is a biotechnology company that specializes in the development of innovative antibody-based immunotherapies for cancer and other diseases. The company was founded in 2011 and is headquartered in Suzhou, China, with additional offices in the United States and Australia.

Adagene's proprietary platform technology, called SAFEbody™, enables the discovery and engineering of highly specific and potent antibodies that target a wide range of disease targets. The company's pipeline includes several preclinical and clinical-stage programs for the treatment of cancer, autoimmune diseases, and infectious diseases.

Adagene has partnerships and collaborations with several leading pharmaceutical companies and research institutions, including Pfizer, Eli Lilly, and the Chinese Academy of Sciences. The company has raised over $150 million in funding to date, including a $69 million Series D financing round in 2020.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X